Elliot W Ehrich

Elliot W Ehrich

UNVERIFIED PROFILE

Are you Elliot W Ehrich?   Register this Author

Register author
Elliot W Ehrich

Elliot W Ehrich

Publications by authors named "Elliot W Ehrich"

Are you Elliot W Ehrich?   Register this Author

11Publications

336Reads

22Profile Views

Mitigation of Olanzapine-Induced Weight Gain With Samidorphan, an Opioid Antagonist: A Randomized Double-Blind Phase 2 Study in Patients With Schizophrenia.

Am J Psychiatry 2019 Jun 8;176(6):457-467. Epub 2019 Mar 8.

Alkermes, Inc., Waltham, Mass. (Martin, Weiden, Jiang, Pathak, DiPetrillo, Silverman, Ehrich); and Hofstra Northwell School of Medicine, Hempstead, N.Y., and Zucker Hillside Hospital, Psychiatry, Glen Oaks, N.Y. (Correll).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.ajp.2018.18030280DOI Listing
June 2019

Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches.

Mol Psychiatry 2019 04 28;24(4):576-587. Epub 2018 Jun 28.

Department of Psychiatry, University of Utah Health Sciences Center, Salt Lake City, UT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41380-018-0117-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310672PMC
April 2019

Effect of aripiprazole lauroxil on agitation and hostility in patients with schizophrenia.

Int Clin Psychopharmacol 2016 Mar;31(2):69-75

aDepartment of Psychiatry & Behavioral Sciences, New York Medical College, Valhalla, New York bAlkermes Inc., Waltham, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/YIC.0000000000000106DOI Listing
March 2016

A placebo-controlled pilot study of the novel opioid receptor antagonist ALKS-33 in binge eating disorder.

Int J Eat Disord 2013 Apr 5;46(3):239-45. Epub 2013 Feb 5.

Lindner Center of HOPE, Research Institute, Mason, OH 45040, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/eat.22114DOI Listing
April 2013

Pharmacokinetics of long-acting naltrexone in subjects with mild to moderate hepatic impairment.

J Clin Pharmacol 2005 Nov;45(11):1259-67

Alkermes, Inc, 88 Sidney Street, Cambridge, MA 02139-4137, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0091270005280199DOI Listing
November 2005

Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial.

JAMA 2005 Apr;293(13):1617-25

Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill 27599-7160, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.293.13.1617DOI Listing
April 2005

Dose-effect relationships of nonsteroidal anti-inflammatory drugs: a literature review.

Clin Ther 2002 Aug;24(8):1225-91

Rheumatology and Rehabilitation Research Unit, Research School of Medicine, University of Leeds, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0149-2918(02)80033-9DOI Listing
August 2002